Research Topics
| G MarchesiniSummaryAffiliation: University of Bologna Country: Italy Publications
| Collaborators
|
Detail Information
Publications
Is liver disease a threat to patients with metabolic disorders?Giulio Marchesini
Unit of Metabolic Diseases, Alma Mater Studiorum University, Bologna, and San Giovanni Battista Hospital, Turin, Italy
Ann Med 37:333-46. 2005....
Diabetes and liver disease: an ominous associationSimona Moscatiello
Unit of Metabolic Diseases, Alma Mater Studiorum University, Policlinico S Orsola, Via Massarenti 9, I 40138 Bologna, Italy
Nutr Metab Cardiovasc Dis 17:63-70. 2007....
Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetesAnna Ludovica Fracanzani
Department of Internal Medicine, Scientific Institute of Recovery and Cure Foundation IRCCS, Hospital Maggiore Policlinico, University of Milan, Milan, Italy
Hepatology 48:792-8. 2008..Alterations in glucose metabolism and insulin resistance in subjects with normal ALT should also be considered in the selection of NAFLD cases for histological assessment of disease severity and progression...
Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndromeGiulio Marchesini
Unit of Metabolic Diseases and Department of Internal Medicine, Alma Mater Studiorum University of Bologna, Bologna, Italy
Hepatology 37:917-23. 2003..The increasing prevalence of obesity, coupled with diabetes, dyslipidemia, hypertension, and ultimately the metabolic syndrome puts a very large population at risk of forthcoming liver failure in the next decades...
Homocysteine and psychological traits: a study in obesityGiulio Marchesini
Department of Internal Medicine and Gastroenterology, Unit of Metabolic Diseases, University of Bologna, Bologna, Italy
Nutrition 18:403-7. 2002..Further, homocysteine might be the link between psychological traits (namely anger and hostility) and cardiovascular disease, mediated by stressful events and sympathetic nervous tone...
Effects of cognitive-behavioural therapy on health-related quality of life in obese subjects with and without binge eating disorderG Marchesini
Unit of Metabolic Diseases, Department of Internal Medicine and Gastroenterology, University of Bologna, Italy
Int J Obes Relat Metab Disord 26:1261-7. 2002..To measure the effects of cognitive-behavioural therapy on health-related quality of life (HRQL) in obese patients, in relation to binge eating disorder...
WHO and ATPIII proposals for the definition of the metabolic syndrome in patients with Type 2 diabetesG Marchesini
Unit of Metabolic Diseases, Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
Diabet Med 21:383-7. 2004..Its identification is of particular importance for coronary risk assessment...
The burden of obesity on everyday life: a role for osteoarticular and respiratory diseasesG Marchesini
Servizio di Malattie del Metabolismo, Alma Mater Studiorum Universita di Bologna, Azienda Ospedaliera S Orsola Malpighi, Via Massarenti 9, 1 40138 Bologna, Italy
Diabetes Nutr Metab 16:284-90. 2003..Osteoarticular and respiratory diseases are major determinants of poor HRQL in obesity. Prevention strategies and treatment of somatic diseases are mandatory for a comprehensive approach to obesity...
Nonalcoholic fatty liver disease: a feature of the metabolic syndromeG Marchesini
Unit of Metabolic Diseases, Department of Internal Medicine and Gastroenterology, University of Bologna, Italy
Diabetes 50:1844-50. 2001..NAFLD may be considered an additional feature of the metabolic syndrome, with specific hepatic insulin resistance...
Nutritional supplementation with branched-chain amino acids in advanced cirrhosis: a double-blind, randomized trialGiulio Marchesini
Department of Internal Medicine, Alma Mater Studiorum University of Bologna, Bologna, Italy
Gastroenterology 124:1792-801. 2003..The role of oral supplementation with branched-chain amino acids (BCAA) in advanced cirrhosis is far from settled. A nutritional approach might prevent progressive liver failure and improve nutritional parameters and quality of life...
Factors associated with poor health-related quality of life of patients with cirrhosisG Marchesini
Universita di Bologna, Bologna, Italy
Gastroenterology 120:170-8. 2001..In cirrhosis, both physical functioning and mental well-being may be altered, but no study has investigated factors associated with a poor perceived health status...
Psychiatric distress and health-related quality of life in obesityG Marchesini
Metabolic Unit, Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
Diabetes Nutr Metab 16:145-54. 2003..In a large proportion of patients psychopathological distress is also present and its role on poor HRQL has never been quantified...
Health-related quality of life in obesity: the role of eating behaviourG Marchesini
Servizio di Malattie del Metabolismo, Universita di Bologna, Azienda Ospedaliera S Orsola Malpighi, Italy
Diabetes Nutr Metab 13:156-64. 2000..Treatment of binge eating may be as important as any weight-reducing intervention for the overall well-being of the majority of obese persons...
Effects of hyperglycaemia and hyperinsulinaemia on plasma amino acid levels in obese subjects with normal glucose toleranceG Marchesini
Department of Internal Medicine and Gastroenterology, Unit of Metabolic Diseases, University of Bologna, Bologna, Italy
Int J Obes Relat Metab Disord 24:552-8. 2000..To investigate the effects of hyperglycaemia and hyperinsulinaemia on amino acid disposal in human obesity...
Are behavioural approaches feasible and effective in the treatment of type 2 diabetes? A propensity score analysis vs. prescriptive dietG Forlani
Unit of Metabolic Diseases, Alma Mater Studiorum University of Bologna, Bologna, Italy
Nutr Metab Cardiovasc Dis 19:313-20. 2009..We report a prospective cohort study, carried out in 822 consecutive subjects with type 2 diabetes, first seen in a 4-year period in a diabetes unit of an academy hospital...
Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndromeG Marchesini
Metabolic Unit, Department of Internal Medicine and Gastroenterology, Alma Mater Studiorum University of Bologna, Bologna, Italy
J Endocrinol Invest 28:333-9. 2005..We conclude that in obesity insulin resistance is a risk factor for raised liver enzyme levels, possibly related to NAFLD...
Eating behavior affects quality of life in type 2 diabetes mellitusF Cerrelli
Unit of Metabolic Diseases, Department of Internal Medicine and Gastroenterology, Alma Mater Studiorum University of Bologna, 40138 Bologna, Italy
Eat Weight Disord 10:251-7. 2005..A disordered eating behavior may be present in T2DM patients, and is associated with poor HRQL. This condition must be considered for an olistic approach to weight control...
Systemic prostaglandin E1 infusion and hepatic aminonitrogen to urea nitrogen conversion in patients with type 2 diabetes in poor metabolic controlG Marchesini
Servizio di Malattie del Metabolismo, , Azienda Ospedaliera S. Orsola-Malpighi, Italy
Metabolism 50:253-8. 2001..We conclude that PGE1 slows the high rate of hepatic urea-N synthesis in poorly controlled type 2 diabetes. Such metabolic effects have therapeutic implications...
Metabolic syndrome, psychological status and quality of life in obesity: the QUOVADIS StudyF Corica
Department of Internal Medicine, University of Messina, Messina, Italy
Int J Obes (Lond) 32:185-91. 2008..In particular, our aim was to investigate the relative impact of physical symptoms, somatic diseases and psychological distress on both the physical and the mental domains of HRQL...
Psychological status and depression in patients with liver cirrhosisG Bianchi
Department of Internal Medicine, Cardioangiology, Hepatology, Alma Mater Studiorum University of Bologna, S Orsola Malpighi Hospital, Via Massarenti 9, I 40138 Bologna, Italy
Dig Liver Dis 37:593-600. 2005..Previous studies reported an impairment of both the physical and mental dimensions of quality of life in patients with cirrhosis. Very few data are available on the psychological impact of the disease and its relation to liver function...
Prevalence of elevated liver enzymes in Type 2 diabetes mellitus and its association with the metabolic syndromeG Forlani
Unit of Metabolic Diseases and Clinical Dietetics, Alma Mater Studiorum University, Bologna, Italy
J Endocrinol Invest 31:146-52. 2008..A large amount of diabetes patients may require a thorough clinical, laboratory and histological investigation...
Impaired insulin-mediated amino acid plasma disappearance in non-alcoholic fatty liver disease: a feature of insulin resistanceG Bianchi
Department of Internal Medicine, Cardioangiology, Hepatology, Universita di Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
Dig Liver Dis 35:722-7. 2003..It is usually measured on glucose metabolism; the effects on amino acid regulation have never been assessed. In particular, no data are available on insulin-dependent branched-chain amino acid metabolism, which is under insulin control...
A controlled, class-based multicomponent intervention to promote healthy lifestyle and to reduce the burden of childhood obesityE Centis
Unit of Metabolic Diseases and Clinical Dietetics, Alma Mater Studiorum University, Bologna, Italy
Pediatr Obes 7:436-45. 2012..Overweight and obesity prevention in childhood and adolescence represent a priority for public health; school is a privileged place for health promotion interventions...
Weight cycling in treatment-seeking obese persons: data from the QUOVADIS studyG Marchesini
Department of Internal Medicine and Gastroenterology, Alma Mater Studiorum University of Bologna, Bologna, Italy
Int J Obes Relat Metab Disord 28:1456-62. 2004..Also, obese patients who do not experience overeating as a loss of control discontinue treatment or regain weight following therapy...
A physical activity program to reinforce weight maintenance following a behavior program in overweight/obese subjectsN Villanova
Department Internal Medicine and Gastroenterology, Unit of Metabolic Diseases, Alma Mater Studiorum University of Bologna, Bologna, Italy
Int J Obes (Lond) 30:697-703. 2006..5%), in spite of further weight loss (-1.8%). CONCLUSION: A specific fitness program in the weight maintenance phase after a behavioral program may significantly improve the long-term control of obesity...
Low ghrelin concentrations in nonalcoholic fatty liver disease are related to insulin resistanceG Marchesini
Unit of Metabolic Diseases, Alma Mater Studiorum, University of Bologna, I 40138 Bologna, Italy
J Clin Endocrinol Metab 88:5674-9. 2003..79; 95% confidence interval, 2.62-12.81; P < 0.0001) and specifically in NAFLD (2.96; 1.12-7.79; P = 0.028). The study suggests that insulin resistance is a major factor controlling ghrelin levels in subjects with and without NAFLD...
Venesection for non-alcoholic fatty liver disease unresponsive to lifestyle counselling--a propensity score-adjusted observational studyL Valenti
Department of Internal Medicine, University of Milan, Fondazione Ospedale Maggiore Policlinico IRCCS, Milan, Italy
QJM 104:141-9. 2011....
The QUOVADIS Study: features of obese Italian patients seeking treatment at specialist centersN Melchionda
University of Bologna, Italy
Diabetes Nutr Metab 16:115-24. 2003....
Snoring, hypertension and Type 2 diabetes in obesity. Protection by physical activityG Marchesini
Dipartimento di Medicina Intema e Gastroenterologia, Alma Mater Studiorum University of Bologna, Italy
J Endocrinol Invest 27:150-7. 2004..These data underline the importance of lifestyle interventions to limit the burden of obesity and associated diseases...
Review article: the treatment of fatty liver disease associated with the metabolic syndromeG Marchesini
Department of Internal Medicine and Gastroenterology, Alma Mater Studiorum, University of Bologna, Bologna, Italy
Aliment Pharmacol Ther 22:37-9. 2005..Several uncontrolled and controlled studies have documented an improvement in liver biochemistry and in histology, but the long-term results remain unsettled. This is an area where significant advances are expected in the next few years...
WHO and ADA criteria for the diagnosis of diabetes mellitus in relation to body mass index. Insulin sensitivity and secretion in resulting subcategories of glucose toleranceN Melchionda
Unit of Metabolic Diseases, Department of Internal Medicine and Gastroenterology, University of Bologna, Policlinico S Orsola, Bologna, Italy
Int J Obes Relat Metab Disord 26:90-6. 2002..A correct identification of the underlying mechanism(s) is the rationale for future studies to detect the effectiveness of different pharmacological or behavioural approaches...
Which treatment for nonalcoholic fatty liver disease?S Moscatiello
Unit of Clinical Dietetics, Alma Mater Studiorum University of Bologna, Policlinico S Orsola, Via Massarenti, 9, I 40138 Bologna, Italy
Mini Rev Med Chem 8:767-75. 2008..Pharmacological treatment is not so far indicated outside controlled clinical trials with histological outcomes...
Reduced quality of life of patients with hepatocellular carcinomaG Bianchi
Department of Internal Medicine, Alma Mater Studiorum University of Bologna, Policlinico S Orsola Malpighi, Via Massarenti 9, 40138 Bologna, Italy
Dig Liver Dis 35:46-54. 2003..It has been shown that health-related quality of life is reduced in patients with cirrhosis and with chronic hepatitis in relation to antiviral therapy. No data are available on patients with hepatocellular carcinoma...
Health-related quality of life in patients with thyroid disordersG P Bianchi
Dipartimento di Medicina Interna, Cardioangiologia, Epatologia, Universita di Bologna, Italy
Qual Life Res 13:45-54. 2004..HRQL was significantly reduced in patients with thyroid diseases referred to a secondary level endocrinology unit. Perceived health status may be considered as an additional outcome of management and therapy of thyroid disorders...
Reduced quality of life in patients with chronic hepatitis C: effects of interferon treatmentG Bianchi
Department of Internal Medicine, University of Bologna, Italy
Dig Liver Dis 32:398-405. 2000..Quality of life is an area of increasing interest in hepatology. Studies, so far, have assessed quality of life in patients with chronic virus C-related hepatitis in relation to antiviral therapy by means of generic questionnaires...
Oxidative stress and anti-oxidant metabolites in patients with hyperthyroidism: effect of treatmentG Bianchi
Dipartimento di Medicina Interna, Cardioangiologia, Epatologia, Universita di Bologna, Policlinico S Orsola, Italy
Horm Metab Res 31:620-4. 1999..Experimental studies showed an elevated oxidative stress during hyperthyroidism, which is reduced by treatment. Therapy per se might decrease oxidative stress...
The direct economic cost of pharmacologically-treated diabetes in Italy-2006. The ARNO observatoryG Marchesini
Unit of Metabolic Diseases and Clinical Dietetics, Alma Mater Studiorum University, Bologna, Italy
Nutr Metab Cardiovasc Dis 21:339-46. 2011..To estimate the prevalence and the direct cost of pharmacologically-treated diabetes in Italy...
An empowerment-based educational program improves psychological well-being and health-related quality of life in Type 1 diabetesG Forlani
Unit of Metabolic Diseases, Department of Internal Medicine and Gastroenterology, Alma Mater Studiorum University, Bologna, Italy
J Endocrinol Invest 29:405-12. 2006..Repeated educational interventions are the way towards a normal life with Type 1 DM...
Liver inflammatory cells, apoptosis, regeneration and stellate cell activation in non-alcoholic steatohepatitisM Susca
Dept. Internal Medicine, University of Bologna, S. Orsola Hospital, Italy
Dig Liver Dis 33:768-77. 2001..This makes liver biopsy an essential part of the clinical setting supporting diagnosis, evaluation of severity and possibly definition of the evolutionary trend...
Hepatic steatosis in obese patients: clinical aspects and prognostic significanceD Festi
Department of Internal Medicine and Gastroenterology, University of Bologna, Bologna, Italy
Obes Rev 5:27-42. 2004..Modifications in lifestyle (e.g. diet and exercise) to reduce obesity remain the mainstay of prevention and treatment of a disease, which puts a large number of individuals at risk of advanced liver disease in the near future...
Splanchnic haemodynamics in non-alcoholic fatty liver disease: effect of a dietary/pharmacological treatment. A pilot studyD Magalotti
Department of Internal Medicine, Cardioangiology and Hepatology, Policlinico S. Orsola-Malpighi, Via Massarenti 9, 40138 Bologna, Italy
Dig Liver Dis 36:406-11. 2004..Vascular changes are reversed by treatment and can be measured by echo-Doppler which may be useful to evaluate the natural course of non-alcoholic fatty liver disease, and to monitor the putative beneficial effects of therapy...
Role of nutrition in gastrointestinal oncological patientsR Di Luzio
Clinical Dietetics, Alma Mater Studiorum University, Bologna, Italy
Eur Rev Med Pharmacol Sci 14:277-84. 2010....
Nonalcoholic fatty liver disease and the metabolic syndromeG Marchesini
Unit of Metabolic Diseases, Department of Internal Medicine and Gastroenterology, Alma Mater Studiorum, University of Bologna, Bologna, Italy
Minerva Cardioangiol 54:229-39. 2006..Prevention and intervention programs based on lifestyle are therefore mandatory to reduce the burden of metabolic liver disease...
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetesElisabetta Bugianesi
Division of Gastro Hepatology, University of Turin, S Giovanni Battista Hospital, Corso Bramante 88, Turin 10126, Italy
Curr Diab Rep 7:175-80. 2007..Although cardiovascular risk remains the major cause for excess mortality in type 2 diabetes mellitus, the risk of progressive liver disease should no longer be underscored...
Iron depletion by phlebotomy improves insulin resistance in patients with nonalcoholic fatty liver disease and hyperferritinemia: evidence from a case-control studyLuca Valenti
Department of Internal Medicine, Universita di Milano, Ospedale Policlinico Mangiagalli Regina Elena IRCCS, Milano, Italy
Am J Gastroenterol 102:1251-8. 2007..Aims of this study were to define the relationship between ferritin and iron stores in patients with NAFLD, the effect of iron depletion on insulin resistance, and whether basal ferritin levels influence treatment outcome...
The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLDPaul Angulo
Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, Rochester, MN 55905, USA
Hepatology 45:846-54. 2007..CONCLUSION: a simple scoring system accurately separates patients with NAFLD with and without advanced fibrosis, rendering liver biopsy for identification of advanced fibrosis unnecessary in a substantial proportion of patients...
Construct validity of the Short Form-36 Health Survey and its relationship with BMI in obese outpatientsFrancesco Corica
Department of Internal Medicine, University of Messina, Messina, Italy
Obesity (Silver Spring) 14:1429-37. 2006....
Correspondence between the International Diabetes Federation criteria for metabolic syndrome and insulin resistance in a cohort of Italian nondiabetic Caucasians: the GISIR databaseGiorgio Sesti
Diabetes Care 30:e33. 2007
Intrauterine growth retardation, insulin resistance, and nonalcoholic fatty liver disease in childrenValerio Nobili
Liver Unit, Research Institute, , Piazza S. Onofrio 4, 00165 Rome, Italy
Diabetes Care 30:2638-40. 2007
Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1Salvatore Petta
Cattedra ed Unità Operativa di Gastroenterologia, University of Palermo, Palermo, Italy
Hepatology 48:28-37. 2008..095; 95% confidence interval, 1.007 to 1.192; P = 0.03). CONCLUSION: In nondiabetic, nonobese patients with genotype 1 CHC, serum RBP4 levels might be the expression of a virus-linked pathway to steatosis, largely unrelated to IR...
Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infectionSalvatore Petta
Cattedra ed Unità Operativa di Gastroenterologia, University of Palermo, Palermo, Italy
Am J Gastroenterol 103:1136-44. 2008..We aimed to assess whether increasing degrees of IR, up to overt diabetes, are linked to steatosis and higher stages of fibrosis in patients with CHC resulting from genotype 1 HCV (G1-HCV)...
Personality dimensions and treatment drop-outs among eating disorder patients treated with cognitive behavior therapyRiccardo Dalle Grave
Department of Eating and Weight Disorder, Villa Garda Hospital, Via Montebaldo, 89, 37016 Garda Vr, Italy
Psychiatry Res 158:381-8. 2008..Eating disorder patients with low Persistence scores are significantly less likely to complete inpatient treatment...
The effect of obesity management on body image in patients seeking treatment at medical centersRiccardo Dalle Grave
Unit of Metabolic Diseases, Alma Mater University of Bologna, Policlinico S Orsola, Via Massarenti, 9, I 40138 Bologna, Italy
Obesity (Silver Spring) 15:2320-7. 2007..Body image dissatisfaction is common in treatment-seeking patients with obesity. We aimed to investigate the effects of obesity management on body image in patients with obesity attending Italian medical centers for weight loss programs...
Psychological distress in morbid obesity in relation to weight historyMaria Letizia Petroni
Nutrition Rehabilitation Unit, IRCCS Istituto Auxologico Italiano, Piancavallo Verbania, Italy
Obes Surg 17:391-9. 2007..In subjects with childhood obesity, psychological distress might be better than in adult-onset obesity, because of progressive adaptation to the social stigma...
Compulsive exercise to control shape or weight in eating disorders: prevalence, associated features, and treatment outcomeRiccardo Dalle Grave
Department of Eating Disorder and Obesity, Villa Garda Hospital, 37016 Garda Vr, Italy
Compr Psychiatry 49:346-52. 2008..The study was aimed at assessing the prevalence of compulsive exercising to control shape and weight in eating disorders (EDs) and its relationship with treatment outcome...
Metabolic syndrome and NASHGiulio Marchesini
Unit of Metabolic Diseases, Department of Internal Medicine and Gastroenterology, Alma Mater Studiorum University of Bologna, Policlinico S Orsola, Bologna, Italy
Clin Liver Dis 11:105-17, ix. 2007..This evidence has precise therapeutic implications: only a behavioral approach to lifestyle correction will address all alterations characterizing the metabolic syndrome, including metabolic liver disease...
Monitoring intervention programmes for out-of-hospital cardiac arrest in a mixed urban and rural settingAndrea Fabbri
Dipartimento dell Emergenza, Azienda USL Forlì, Italy
Resuscitation 71:180-7. 2006....
Gender, fatty liver and GGTLucia Carulli
Hepatology 44:278-9. 2006
NASH: from liver diseases to metabolic disorders and back to clinical hepatologyGiulio Marchesini
Hepatology 35:497-9. 2002
Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver studyGiorgio Bedogni
Centro Studi Fegato, Area Science Park, Basovizza, and Department of BBCM, University of Trieste, Italy
Hepatology 42:44-52. 2005..In conclusion, NAFLD is highly prevalent in the general population, is not associated with SLD, but is associated with many features of the metabolic syndrome...
A randomized controlled trial of metformin versus vitamin E or prescriptive diet in nonalcoholic fatty liver diseaseElisabetta Bugianesi
Department of Gastroenterology, University of Turin, Italy
Am J Gastroenterol 100:1082-90. 2005..Limited histological data support an association between improved aminotransferases and biopsy findings, which require confirmation in a double-blind trial with appropriate statistical power based on liver histology...
Plasma adiponectin in nonalcoholic fatty liver is related to hepatic insulin resistance and hepatic fat content, not to liver disease severityElisabetta Bugianesi
Division of Gastroenterology, University of Turin, Ospedale San Giovanni Battista, Corso Bramante 88, I 10126 Torino, Italy
J Clin Endocrinol Metab 90:3498-504. 2005..Hypoadiponectinemia in NAFLD is part of a metabolic disturbance characterized by ectopic fat accumulation in the central compartment...
Weight loss expectations in obese patients seeking treatment at medical centersRiccardo Dalle Grave
Department of Nutritional Rehabilitation, Villa Garda Hospital, Garda, Italy
Obes Res 12:2005-12. 2004..DISCUSSION: Obese Italian patients had unrealistic weight loss expectations. There were significant disparities between patients' perceptions and physicians' weight loss recommendations of desirable treatment outcome...
Update on nutritional supplementation with branched-chain amino acidsGiampaolo Bianchi
Department of Internal Medicine, Alma Mater Studiorum University of Bologna, Bologna, Italy
Curr Opin Clin Nutr Metab Care 8:83-7. 2005..There is a need for long-term, randomized clinical studies, both in the prevention and in the treatment of various pathological conditions...
Plasma ghrelin concentrations, food intake, and anorexia in liver failureGiulio Marchesini
Department of Internal Medicine and Gastroenterology, Alma Mater Studiorum University of Bologna, I 40138 Bologna, Italy
J Clin Endocrinol Metab 89:2136-41. 2004..In the presence of anorexia, hyperghrelinemia might indicate a compensatory mechanism trying to stimulate food intake, which is nonetheless ineffective in the physiological range...
The metabolic syndrome in treatment-seeking obese personsGiulio Marchesini
Department of Diabetes and Endocrinology, Birmingham Heartlands Hospital, Birmingham, UK
Metabolism 53:435-40. 2004..It is time to move towards a more integrated approach and to reconsider resource allocation to improve lifestyle changes for large-scale control of obesity...
Relative contribution of iron burden, HFE mutations, and insulin resistance to fibrosis in nonalcoholic fatty liverElisabetta Bugianesi
Division of Gastro Hepatology, Department of Internal Medicine, University of Turin, Turin, Italy
Hepatology 39:179-87. 2004..Increased ferritin levels are markers of severe histologic damage, but not of iron overload. Iron burden and HFE mutations do not contribute significantly to hepatic fibrosis in the majority of patients with NAFLD...
Non-alcoholic steatohepatitis in patients cared in metabolic unitsGiulio Marchesini
Unit of Metabolic Diseases, Department of Internal Medicine and Gastroenterology, University of Bologna, Alma Mater Studiorum, Via Massarenti 9, Policlinico S Orsola, I 40138 Bologna, Italy
Diabetes Res Clin Pract 63:143-51. 2004..Liver biopsy is recommended for diagnostic and prognostic purposes, as well as for testing treatment effects in controlled trials...
Expanding the natural history of nonalcoholic steatohepatitis: from cryptogenic cirrhosis to hepatocellular carcinomaElisabetta Bugianesi
Department of Gastroenterology, Ospedale S Giovanni Battista, University of Turin, Turin, Italy
Gastroenterology 123:134-40. 2002..Nonalcoholic steatohepatitis (NASH) may progress to cirrhosis; whether NASH plays also a role in the development of hepatocellular carcinoma (HCC) is unknown...
Effects of long-term oral misoprostol administration on hepatic amino acid-nitrogen metabolism in patients with cirrhosisGiampaolo Bianchi
Dipartimento di Medicina Interna, Cardioangiologia, Epatologia, Alma Mater Studiorum, Universita di Bologna, Policlinico S Orsola Malpighi, Bologna, Italy
J Hepatol 37:15-21. 2002..The acute infusion of a Prostaglandin of E series 1 (PGE1) analogue results in nitrogen sparing in cirrhosis...
Branched-chain amino acid supplementation in patients with liver diseasesGiulio Marchesini
Department of Internal Medicine, Alma Mater Studiorum, University of Bologna, Italy
J Nutr 135:1596S-601S. 2005..The number of patients who cannot tolerate dietary proteins in amounts sufficient to meet the higher catabolism of advanced liver disease is probably low, but BCAAs remain the sole treatment of proved efficacy in this specific setting...
Insulin resistance: a metabolic pathway to chronic liver diseaseElisabetta Bugianesi
Gastroenterology Department, University of Turin, Turin, Italy
Hepatology 42:987-1000. 2005..Finally, the ability of insulin-sensitizing, pharmacological agents to treat NAFLD by reducing IR in the liver (metformin) and in the periphery (thiazolidinediones) are discussed...
Weight loss expectations in obese patients and treatment attrition: an observational multicenter studyRiccardo Dalle Grave
Villa Garda Hospital, Garda, Verona, Italy
Obes Res 13:1961-9. 2005..Unrealistic weight goals should be tackled at the very beginning of treatment...
A positive blood alcohol concentration is the main predictor of recurrent motor vehicle crashAndrea Fabbri
Dipartimento di Urgenza Accettazione, Azienda Unità Sanitaria Locale di Forlì, Forli, Italy
Ann Emerg Med 46:161-7. 2005..Our objective is to determine the main variables predicting recurrent crashes in subjects attending an emergency department (ED) for injuries after motor vehicle crash...
Nonalcoholic fatty liver disease and the metabolic syndromeGiulio Marchesini
Unit of Metabolic Diseases, Alma Mater Studiorum University of Bologna, Italy
Curr Opin Lipidol 16:421-7. 2005..Insulin resistance is the common factor connecting obesity, diabetes, hypertension and dyslipidemia with fatty liver and the progression of hepatic disease to steatohepatitis, fibrosis, cirrhosis and hepatocellular carcinoma...
Hepatotoxicity of fast food?Giulio Marchesini
Clinical Dietetics, Alma Mater Studiorum University of Bologna, S Orsola Malpighi Hospital, 9, Via Massarenti, I 40138 Bologna, Italy
Gut 57:568-70. 2008
Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatmentElisabetta Bugianesi
Department of Gastroenterology, San Giovanni Battista Hospital, University of Turin, Corso Bramante 88, I 10127 Turin, Italy
Best Pract Res Clin Gastroenterol 18:1105-16. 2004..Large, long-term, placebo-controlled randomized studies are eagerly awaited. Outside controlled studies, nutritional counselling and physical exercise aimed at moderate weight loss remain the basis of any therapeutic intervention...
Type 2 diabetes and the Naaman syndromeGiulio Marchesini
Diabetes Care 26:3195. 2003
The effect of inpatient cognitive-behavioral therapy for eating disorders on temperament and characterRiccardo Dalle Grave
Department of Eating and Weight Disorder, Villa Garda Hospital, Garda, Verona, Italy
Behav Res Ther 45:1335-44. 2007..These results are relevant for future studies based on TCI...
Adherence to chronic cardiovascular therapies: persistence over the years and dose coverageElisabetta Poluzzi
Department of Pharmacology, University of Bologna, Bologna, Italy
Br J Clin Pharmacol 63:346-55. 2007..To evaluate adherence to chronic cardiovascular drug treatments, in terms of long-term persistence and dose coverage...
Diabetes prevention strategy in offspring of type 2 diabetic patients with a direct involvement of the diseased parentsKatia Bonomo
Nutr Metab Cardiovasc Dis 15:237-8. 2005
Insulin glargine improves glycemic control and health-related quality of life in type 1 diabetesRita Manini
Unit of Metabolic Disease, Alma Mater Studiorum University of Bologna, S Orsola Hospital, Via Massarenti 9, 40138 Bologna, Italy
Nutr Metab Cardiovasc Dis 17:493-8. 2007..To date, only one study has measured the effects of glargine on health-related quality of life (HRQL); the aim of this study was therefore to confirm the beneficial effects of glargine on disease-specific HRQL in type 1 diabetes...
NAFLD treatment: cognitive-behavioral therapy has entered the arenaGiulio Marchesini
J Hepatol 43:926-8. 2005
Metabolic syndrome and health-related quality of life: does psychological well-being matter?Andrea Corsonello
Ann Epidemiol 18:592-3. 2008
Endothelial dysfunction and cardiovascular risk profile in nonalcoholic fatty liver diseaseNicola Villanova
Unit of Metabolic Diseases, Alma Mater Studiorum University of Bologna, Policlinico S. Orsola-Malpighi, Via Massarenti 9, I-40138 Bologna, Italy
Hepatology 42:473-80. 2005..The risk of advanced liver disease is well recognized in NAFLD patients, but the large majority of cases might experience cardiovascular disease in the long term, indirectly limiting the burden of liver failure...
Update on branched-chain amino acid supplementation in liver diseasesGiampaolo Bianchi
Department of Internal Medicine, Alma Mater Studiorum' University of Bologna, Italy
Curr Opin Gastroenterol 21:197-200. 2005..Although the number of patients who cannot tolerate dietary proteins in amounts sufficient to meet their increased catabolism is probably low, in this specific setting BCAAs remain the sole treatment of proved efficacy...
Behavior therapy for nonalcoholic fatty liver disease: The need for a multidisciplinary approachStefano Bellentani
Liver and Nutrition Center, Ramazzini Hospital, Carpi, Modena, Italy
Hepatology 47:746-54. 2008..Alternatively, general practitioners and physicians working in gastrointestinal units should limit their intervention to engage patients with NAFLD before referral to specialized teams set up for the treatment of diabetes and obesity...
Non-alcoholic fatty liver disease (NAFLD)--a novel common aspect of the metabolic syndromeKaterina Bogdanova
Department of Pathological Physiology, Faculty of Medicine, Palacky University, Olomouc, Czech Republic
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 150:101-4. 2006..There is urgent need in terms of both intensive research pursuits and effective practical measures to deal with this common threat...
